Inflammation / NLRP3 / Pyroptosis / Complement
Sources covering the Pipeline of Inflammation arc: NLRP3 structure / toxicity / Tx, NLRP3 inhibitor (Marianthi, PFR-4231-100), CAPS, pyroptosis MOA and assays, inflammasome / interferon / cytokine omics, Complement / C5aR1 (Woodruff), Havrda, In Vivo strategy (Katy), and 4 LPS.
Source-of-truth pages live in data/processed/markdown/by-photo/. Each row below points first to the KB source note (which carries the heading list) and then to the canonical transcription.
Sources in this section: 42
Top-level nav clusters: 19
Pipeline of Inflammation
14 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183121 | Page 626 of 632 | Pipeline of Inflammation > Pyroptosis MOA > Pyroptosis evidence/MOA/Correction in PD | note | md |
20240722_183125 | Page 651 of 660 | Pipeline of Inflammation > Pyroptosis MOA | note | md |
20240722_183128 | Page 651 of 660 | Pipeline of Inflammation > Pyroptosis MOA > Pyroptosis evidence/MOA | note | md |
20240722_183141 | Page 661 of 670 | Pipeline of Inflammation > CAPS > WBC > Dx > ARP > Sx | note | md |
20240722_183153 | Page 661 of 670 | Pipeline of Inflammation > Pipeline CAPS > Animal model > TM > NLRP3 inhibitor (Marianthi) (PFR-4231-100) | note | md |
20240722_183206 | Page 695 of 701 | Pipeline of Inflammation > Pipeline CAPS > NLRP3 inhibitor (Marianthi) (PFR-4231-100) > AD > Assays of pyroptosis | note | md |
20240722_183218 | Page 698 of 704 | Pipeline of Inflammation > NLRP3 inhibitor (Marianthi) > AD > Chemistry > Clinical > Comp Bio > Competitor | note | md |
20240722_183231 | Page 713 of 719 | Pipeline of Inflammation > NLRP3 inhibitor (Marianthi) > In Vivo strategy > Havrda > HED > IHC | note | md |
20240722_183244 | Page 733 of 738 | Pipeline of Inflammation > NLRP3 inhibitor (Marianthi) > Katy > Longitudinal > Metabolomics > Microglial Imaging | note | md |
20240722_183255 | Page 744 of 750 | Pipeline of Inflammation > NLRP3 inhibitor (Marianthi) > Microglial Imaging > NHP > PDE > PE > PET | note | md |
20240722_183308 | Page 747 of 753 | Pipeline of Inflammation > NLRP3 inhibitor (Marianthi) > PK/PD > PK/PD Strategy > Postmortem > Proteina | note | md |
20240722_183321 | Page 765 of 776 | Pipeline of Inflammation > NLRP3 inhibitor (Marianthi) > Reactome > Safety > Screening flow > ShareFolder | note | md |
20240722_183335 | Page 782 of 789 | Pipeline of Inflammation > Complement / C5aR1 > MOA > Woodruff’s study plan > Screening > DD | note | md |
20240722_183348 | Page 792 of 798 | Pipeline of Inflammation > Postmortem > Imaging of Iron > IT > Jaya | note | md |
Inflammation
5 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183147 | Page 661 of 670 | Inflammation > NLRP3 > Tx | note | md |
20240722_183159 | Page 661 of 670 | Inflammation > NLRP3 inhibitor (Marianthi) > AD > Assays of pyroptosis | note | md |
20240722_183225 | Page 713 of 719 | Inflammation > Competitor > Havrda | note | md |
20240722_183238 | Page 726 of 732 | Inflammation > In Vivo strategy > Katy | note | md |
20240722_184357 | Page 1036 of 1044 | Inflammation > 기타 MOA들 > Pittsburgh University > Greenamyre Lab | note | md |
Assays of pyroptosis
2 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183203 | Page 695 of 701 | Assays of pyroptosis | note | md |
20240722_183208 | Page 698 of 704 | Assays of pyroptosis > Budget & FTE > Ceri > Chemistry | note | md |
Imaging neuroinflammation
2 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183104 | Page 626 of 632 | Imaging neuroinflammation | note | md |
20240722_183108 | Page 626 of 632 | Imaging neuroinflammation > DPA714 > 3rd Generation TSPO | note | md |
In Vivo strategy
2 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183234 | Page 713 of 719 | In Vivo strategy > Katy | note | md |
20240722_183241 | Page 726 of 732 | In Vivo strategy > Katy > Longitudinal | note | md |
NLRP3
2 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183132 | Page 661 of 670 | NLRP3 > Structure | note | md |
20240722_183144 | Page 661 of 670 | NLRP3 > Toxicity | note | md |
NLRP3 inhibitor (Marianthi) (P…)
2 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183156 | Page 661 of 670 | NLRP3 inhibitor (Marianthi) (P…) > AD > Assays of pyroptosis | note | md |
20240722_183222 | NLRP3 inhibitor (Marianthi) (P…) > Pipeline / Competitors | note | md |
Stratification strategy on…
2 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183521 | Page 882 of 889 | Stratification strategy on… | note | md |
20240722_184310 | Page 984 of 994 | Stratification strategy on… > Pathogenicity of variant | note | md |
[GT]
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184743 | Page 1256 of 1262 | [GT] > AAV > Capsid (serotype) | note | md |
Assays of pyroptosis (cytokine / chemokine omics)
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183215 | Page 698 of 704 | Assays of pyroptosis (cytokine / chemokine omics) > AD | note | md |
Background
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183342 | Page 788 of 796 | Background > Pipeline C5aR1 > Innomedica (Haven) > In Vivo Clibration | note | md |
Comp Bio
1 source page
Cryopyrin-Associated Periodic Syndromes (CAPS)
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183138 | Page 661 of 670 | Cryopyrin-Associated Periodic Syndromes (CAPS) | note | md |
Havrda
1 source page
Minee Choi
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183354 | Page 798 of 805 | Minee Choi > Kv1.3 > Kyoko Yoshikawa > Lee Jonghun | note | md |
Pipeline CAPS
1 source page
Pyroptosis evidence/MOA…
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183351 | Page 798 of 805 | Pyroptosis evidence/MOA… | note | md |
Pyroptosis MOA
1 source page
Stratification strategy on neuroinflammation
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_183332 | Page 779 of 784 | Stratification strategy on neuroinflammation > RNA-Seq (Daria) > C5aR1 (Woodruff, Univ of Queensland) | note | md |